SCHEMBL17876269

SCHEMBL17876269

c1ccc(N2Cc3cc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)ccc3-c3cc(-c4cccc5oc6ccccc6c45)ccc3C2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 6/20 0.36
CYP11B2 P19099 6/20 0.36
CYP1A2 P05177 3/20 0.35
TDP2 O95551 2/20 0.35
PRKDC P78527 2/20 0.35
ALK Q9UM73 1/20 0.35
CYP19A1 P11511 2/20 0.34
PGR P06401 1/20 0.34
PDE10A Q9Y233 1/20 0.33
CYP3A4 P08684 3/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
CYP17A1 P05093 1/20 0.33
PDK2 Q15119 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876255 1.00 CYP11B1 (0.36) CYP11B1CYP11B2CYP1A2TDP2PRKDC
SCHEMBL17876311 0.96 ALK (0.36) CYP11B1CYP11B2CYP1A2TDP2PRKDC
SCHEMBL17876254 0.91 PRKDC (0.37) PRKDCALK
SCHEMBL17876261 0.91 PRKDC (0.37) PRKDCALK
SCHEMBL17876235 0.90 ALOX5 (0.39) CYP11B1CYP11B2CYP1A2TDP2PRKDC
SCHEMBL17876267 0.90 ALOX5 (0.39) CYP11B1CYP11B2CYP1A2TDP2PRKDC
SCHEMBL17876266 0.90 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17876268 0.90 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17876240 0.90 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2CYP19A1
SCHEMBL17876245 0.90 CYP11B1 (0.37) CYP11B1CYP11B2CYP1A2TDP2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP1A2 757/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP1A2 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.